{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T20:06:00Z","timestamp":1776197160417,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010814","name":"Anhui Provincial Department of Education","doi-asserted-by":"publisher","award":["2022xscx055"],"award-info":[{"award-number":["2022xscx055"]}],"id":[{"id":"10.13039\/501100010814","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.intimp.2026.116544","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T19:40:27Z","timestamp":1774035627000},"page":"116544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["LAMC3 promotes the development of prostate cancer via modulating the cell cycle progression"],"prefix":"10.1016","volume":"177","author":[{"given":"Lei","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hekang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qintao","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingfan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaozhao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116544_bb0005","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.intimp.2026.116544_bb0010","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1464-410X.2005.05798.x","article-title":"A retrospective study of the time to clinical endpoints for advanced prostate cancer","volume":"96","author":"Sharifi","year":"2005","journal-title":"BJU Int."},{"key":"10.1016\/j.intimp.2026.116544_bb0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canlet.2021.10.028","article-title":"Fibroblast heterogeneity in prostate carcinogenesis","volume":"525","author":"ChallaSivaKanaka","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2026.116544_bb0020","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1038\/s41388-019-0805-7","article-title":"Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer","volume":"38","author":"Ippolito","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2026.116544_bb0025","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","article-title":"Unmasking senescence: context-dependent effects of SASP in cancer","volume":"19","author":"Faget","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.116544_bb0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12943-024-02096-7","article-title":"Cellular senescence and SASP in tumor progression and therapeutic opportunities","volume":"23","author":"Dong","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.116544_bb0035","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/14728222.2019.1565658","article-title":"Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype","volume":"23","author":"Lau","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.intimp.2026.116544_bb0040","doi-asserted-by":"crossref","first-page":"12072","DOI":"10.1073\/pnas.211053698","article-title":"Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging","volume":"98","author":"Krtolica","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.116544_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.183","article-title":"Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells","volume":"3","author":"Cahu","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.116544_bb0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ccell.2020.10.012","article-title":"Senescence reprogramming by TIMP1 deficiency promotes prostate cancer metastasis","volume":"39","author":"Guccini","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.116544_bb0055","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.18632\/aging.102172","article-title":"The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells","volume":"11","author":"Alessio","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.intimp.2026.116544_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114765","article-title":"Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy","volume":"193","author":"Carpenter","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116544_bb0065","first-page":"258","article-title":"Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer","volume":"21","author":"Mori","year":"2024","journal-title":"Nat. Rev."},{"key":"10.1016\/j.intimp.2026.116544_bb0070","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116544_bb0075","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbcan.2018.09.001","article-title":"PI3K pathway in prostate cancer: all resistant roads lead to PI3K","volume":"1870","author":"Park","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.116544_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120046","article-title":"Palmitic acid inhibits prostate cancer cell proliferation and metastasis by suppressing the PI3K\/Akt pathway","volume":"286","author":"Zhu","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2026.116544_bb0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.116544_bb0090","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3892\/ijo.2014.2601","article-title":"Targeting the PI3K\/Akt pathway in prostate cancer: challenges and opportunities (review)","volume":"45","author":"Toren","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2026.116544_bb0095","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.bcp.2012.07.012","article-title":"Dietary flavonoid fisetin: a novel dual inhibitor of PI3K\/Akt and mTOR for prostate cancer management","volume":"84","author":"Adhami","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116544_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1552","article-title":"Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: implications for prognosis and therapy prediction","volume":"14","author":"Ge","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.intimp.2026.116544_bb0105","article-title":"Single-cell RNA-seq reveals a developmental hierarchy super-imposed over subclonal evolution in the cellular ecosystem of prostate cancer","volume":"9","author":"Ge","year":"2022","journal-title":"Adv. Sci. (Weinh., Baden-Wurttemb., Ger.)."},{"key":"10.1016\/j.intimp.2026.116544_bb0110","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41467-023-36325-2","article-title":"Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses","volume":"14","author":"Hirz","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116544_bb0115","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.3192","article-title":"Spatial reconstruction of single-cell gene expression data","volume":"33","author":"Satija","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.intimp.2026.116544_bb0120","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.116544_bb0125","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/gb-2014-15-3-r47","article-title":"Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines","volume":"15","author":"Geeleher","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.intimp.2026.116544_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.intimp.2026.116544_bb0135","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.intimp.2026.116544_bb0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2026.116544_bb0145","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcac010","article-title":"A m(6)Avalue predictive of prostate cancer stemness, tumor immune landscape and immunotherapy response","volume":"4","author":"Zou","year":"2022","journal-title":"NAR Cancer."},{"key":"10.1016\/j.intimp.2026.116544_bb0150","article-title":"Hydrogen therapy reverses cancer-associated fibroblasts phenotypes and remodels stromal microenvironment to stimulate systematic anti-tumor immunity","volume":"11","author":"Meng","year":"2024","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.intimp.2026.116544_bb0155","article-title":"Targeted reprogramming of vitamin B(3) metabolism as a nanotherapeutic strategy towards chemoresistant cancers","volume":"35","author":"Guo","year":"2023","journal-title":"Adv. Mater. (Deerfield Beach, Fla)."},{"key":"10.1016\/j.intimp.2026.116544_bb0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/ERC-18-0196","article-title":"ATM deficiency promotes progression of CRPC by enhancing Warburg effect","volume":"26","author":"Xu","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.intimp.2026.116544_bb0165","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/modpathol.2017.44","article-title":"FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate","volume":"30","author":"Park","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.intimp.2026.116544_bb0170","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2012748118","article-title":"A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer","volume":"118","author":"Xu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.116544_bb0175","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","article-title":"Cellular senescence: defining a path forward","volume":"179","author":"Gorgoulis","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116544_bb0180","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12964-019-0434-3","article-title":"CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition","volume":"17","author":"Lu","year":"2019","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.intimp.2026.116544_bb0185","first-page":"757","article-title":"Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis","volume":"32","author":"Pulukuri","year":"2008","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2026.116544_bb0190","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.pcan.4500984","article-title":"Neutral endopeptidase inhibits prostate cancer tumorigenesis by reducing FGF-2-mediated angiogenesis","volume":"11","author":"Horiguchi","year":"2008","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.intimp.2026.116544_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105306","article-title":"\u03b4-Catenin participates in EGF\/AKT\/p21(Waf) signaling and induces prostate cancer cell proliferation and invasion","volume":"22","author":"Shen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116544_bb0200","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.intimp.2016.08.017","article-title":"IL-7\/IL-7 receptor axis stimulates prostate cancer cell invasion and migration via AKT\/NF-\u03baB pathway","volume":"40","author":"Qu","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116544_bb0205","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1158\/0008-5472.CAN-12-3228","article-title":"Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling","volume":"73","author":"Fang","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.116544_bb0210","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/carcin\/bgs312","article-title":"Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and \u22122","volume":"33","author":"Killian","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.intimp.2026.116544_bb0215","article-title":"Icariin inhibits prostate cancer bone metastasis and destruction via suppressing TAM\/CCL5-mediated osteoclastogenesis","volume":"120","author":"Chen","year":"2023","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.intimp.2026.116544_bb0220","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.celrep.2014.05.045","article-title":"EZH2-mediated inactivation of IFN-\u03b3-JAK-STAT1 signaling is an effective therapeutic target in MYC-driven prostate cancer","volume":"8","author":"Wee","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2026.116544_bb0225","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nmeth.4437","article-title":"Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations","volume":"14","author":"van den Brink","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.intimp.2026.116544_bb0230","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giaa151","article-title":"SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data","volume":"9","author":"Young","year":"2020","journal-title":"GigaScience"},{"key":"10.1016\/j.intimp.2026.116544_bb0235","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s41467-020-14976-9","article-title":"Embracing the dropouts in single-cell RNA-seq analysis","volume":"11","author":"Qiu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116544_bb0240","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.2147\/IJN.S203113","article-title":"Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer","volume":"14","author":"Zhang","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.intimp.2026.116544_bb0245","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12943-021-01443-2","article-title":"ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.116544_bb0250","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1021\/acsnanoscienceau.4c00066","article-title":"Lipid nanoparticle delivery of mRNA and siRNA for concurrent restoration of tumor suppressor and inhibition of tumorigenic driver in prostate cancer","volume":"5","author":"Farokhzad","year":"2025","journal-title":"ACS Nanosci. Au"},{"key":"10.1016\/j.intimp.2026.116544_bb0255","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/17425247.2025.2466767","article-title":"GalNac-siRNA conjugate delivery technology promotes the treatment of typical chronic liver diseases","volume":"22","author":"Qin","year":"2025","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.intimp.2026.116544_bb0260","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1039\/D5TB00575B","article-title":"Versatility of LNPs across different administration routes for targeted RNA delivery","volume":"13","author":"Jallow","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.intimp.2026.116544_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1772","article-title":"Targeting senescence-associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes","volume":"14","author":"Xiong","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.intimp.2026.116544_bb0270","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1158\/1538-7445.AM2025-300","article-title":"Abstract 300: senescence and secreted factors: implication of DNA damage response pathways","volume":"85","author":"Desmul","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.116544_bb0275","article-title":"Impact and potential value of immunosenescence on solid gastrointestinal tumors","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116544_bb0280","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.euo.2023.07.013","article-title":"Combining PARP inhibitors and androgen receptor signalling inhibitors in metastatic prostate cancer: a quantitative synthesis and meta-analysis","volume":"7","author":"Messina","year":"2024","journal-title":"Eur. Urol. Oncol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926003899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926003899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:12:26Z","timestamp":1776193946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926003899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":56,"alternative-id":["S1567576926003899"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116544","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LAMC3 promotes the development of prostate cancer via modulating the cell cycle progression","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116544"}}